Track topics on Twitter Track topics that are important to you
The stable isotopelabeled compounds market is projected to grow at a CAGR of 2.94%.
The global stable isotopelabeled compounds market is estimated to grow at a CAGR of 2.94% from 2017 to 2022, to reach USD 294.2 million by 2022. Increase in research activities in the pharmaceutical and biotechnology sector, growing proteomics research, and rising prevalence of cancer are the major factors driving the growth of this market. However, the high cost of stable isotopelabeled compounds is expected to hinder the growth of the market to a certain extent during the forecast period.
The Deuterium H2 segment is expected to grow at the highest CAGR during the forecast period.
On the basis of type, the stable isotopelabeled compounds market is segmented into Carbon13, Deuterium H2, Oxygen18, Nitrogen15, and others noble gases and metals. In 2017, the H2 segment is expected to account for the largest share of the market and is projected to grow at the highest CAGR during the forecast period. Increasing use of H2 in several research and industrial applications is expected to drive the growth of this market segment.
The pharmaceutical biotechnology companies segment is projected to grow at the highest CAGR during the forecast period.
Based on end user, the stable isotopelabeled compounds market is segmented into pharmaceutical and biotechnology companies, hospitals and diagnostic centers, academic research institutes, and other end users contract research organizations, food beverage companies, and forensic laboratories. During the forecast period, the pharmaceutical and biotechnology companies segment is expected to grow at the highest CAGR. This growth is mainly due to the increased use of stable isotopelabeled compounds in RD in the pharmaceutical and biotechnology sector.
North America to witness the highest growth during the forecast period.
In 2017, North America is projected to account for the largest share of the global stable isotopelabeled compounds market. Growth of the pharmaceutical and biopharmaceutical industry, support for this sector from the Isotope Production and Distribution Program Fund, the presence of a large nuclear industry in the U.S, growth of the Canadian pharmaceutical industry, and the rising adoption of PET imaging in Canada are the key factors responsible for the growth of this market in the North America region.
Break of primary participants was as mentioned below:
By Company Type Tier 185%, Tier 29% and Tier 36%
By Designation Clevel81%, Director Level10%, Others9%
By Region North America40%, Europe20%, AsiaPacific29%, RoW11%
Some of the major players in the stable isotopelabeled compounds market include Cambridge Isotopes Laboratories, Inc. U.S., Merck KGaA Germany, URENCO U.K., Omicron Biochemicals, Inc. U.S., JSC Isotope Russia, Trace Science International U.S., IsoSciences U.S., Taiyo Nippon Sanso Corporation Japan, Nordion Inc. Canada, and Medical Isotopes, Inc. U.S..
The report analyzes the stable isotopelabeled compounds market and aims at estimating the market size and future growth potential based on various segments such as type, application, end user, and region. The report also includes an indepth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the belowmentioned five strategies.
This report provides insights on the following pointers:
Market Penetration: Comprehensive information on product and service portfolios offered by the top players in the global stable isotopelabeled compounds market. The report analyzes the global market by type, application, end user, and region
Service Enhancement/Innovation: Detailed insights on upcoming trends and new service launches in the global stable isotopelabeled compounds market
Market Development: Comprehensive information on the lucrative emerging markets by type of stable isotopelabeled compounds, application, end user, and region
Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global stable isotopelabeled compounds market
Competitive Assessment: Indepth assessment of market shares, growth strategies, products, services, and capabilities of reprocessing of stable isotopelabeled compounds of leading players in the global market
Original Article: Stable Isotope Labeled Compounds Market by Type C13, D, 018, N15 label, Application Research, Clinical Diagnostics, Industrial, End User Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospital Global Forecast to 2022 [ReporNEXT ARTICLE
Bioscience - any of the sciences that deal with living organisms. The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...